Skip to main content

Impact Features

Dynamic teams of physicians, researchers, patients, and patient advocates work together in each RDCRN consortium to advance rare diseases research. This page collects feature articles highlighting both the work of the RDCRN consortia and the people behind that work. Choose the consortium acronym at the top of the page to view features articles related to that consortium.

Click here for a complete list of all RDCRN consortia.

Keyword co-occurrence visualization map of RDCRN-supported publications 2004–2020.

January 29, 2024

The Rare Diseases Act of 2002 (H.R. 4013) enacted the establishment of the Rare Diseases Clinical Research Network (RDCRN) in 2003.

Osteogenesis Imperfecta Over Time: What We’re Learning from a Natural History Study

September 22, 2023


November 22, 2021

We are launching a new article series that offers a window into rare diseases research with this issue of the Spotlight newsletter.

Michelle Fynan, PhD, LMHC

November 16, 2021

Michelle Fynan, PhD, LMHC, shares her journey with OI, from adolescent struggles to finding her purpose as an OI activist and researcher.

Chaya Nautiyal Murali, MD,

November 9, 2021

Chaya Nautiyal Murali, MD, a pediatric geneticist at Baylor College of Medicine, discusses her start in rare disease research, exciting discoveries,…

Brendan Lee, MD, PhD,

November 3, 2021

Brittle Bone Disorders Consortium (BBDC) principal investigator Brendan Lee, MD, PhD, and Vernon Sutton, MD, share the history of the…

Patient Advocate Tracy Hart, CEO of the OI Foundation (left) with Ingunn Westerheim, president of the OI Federation Europe

January 26, 2021

Tracy Hart, chief executive officer of the Osteogenesis Imperfecta Foundation, serves as chair of the Rare Diseases Clinical Research Network (RDCRN…